Company profile: Organix
1.1 - Company Overview
Company description
- Provider of organic synthesis services across all areas of organic chemistry, partnering with biotech, pharmaceutical, and government clients. Offerings include custom synthesis (new chemical entities, phosphoramidites, drug conjugates), GMP-grade lipid synthesis, medicinal chemistry, contract R&D, analytical services (NMR, mass spectrometry), and polymer conjugates (PEG, HPMA).
Products and services
- Medicinal Chemistry: Organix delivers discovery-focused synthetic organic and medicinal chemistry services, concentrating on drug discovery and development processes for biotech, pharmaceutical, and government clients
- Custom Synthesis: Organix fabricates custom-engineered molecules—including new chemical entities, phosphoramidites, and drug conjugates—precisely tailored to client needs in organic chemistry
- GMP Lipid Services: Organix produces GMP-grade specialty lipids for research and drug delivery applications, supplying a variety through dedicated lipid synthesis services
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Organix
Clinvest Research
HQ: United States
Website
- Description: Provider of clinical research services conducting clinical trials for headache and migraine, arthritis and joint pain, diabetes and weight management, and vaccines (flu, RSV, COVID). Partners with pharmaceutical companies to study and develop new treatments and health strategies, providing participants access to new treatments before they are widely available.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinvest Research company profile →
Medical Science & Computing
HQ: United States
Website
- Description: Provider of advanced data analytics and AI to support health, human services, and public safety missions; enterprise digital modernization and system integration; and cloud adoption and infrastructure optimization to enhance performance, reduce costs, improve public health, strengthen research and IT capabilities, and optimize operational outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medical Science & Computing company profile →
Crown Bioscience
HQ: United States
Website
- Description: Provider of translational preclinical research solutions for oncology, cardiovascular, and metabolic disease drug discovery, including patient-derived xenograft (PDX) models, organoid and cell line models, in vitro screening and pharmacology characterization, in vivo development support, cancer model databases, and high-content imaging to analyze tumor growth and disease progression.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Crown Bioscience company profile →
Central Research Associates
HQ: United States
Website
- Description: Provider of multi-specialty clinical services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Central Research Associates company profile →
ADVI Health
HQ: United States
Website
- Description: Provider of boutique health care advisory services, including market access and pricing strategy; federal and state policy monitoring and modeling; strategic analytics, value and economics; coding and reimbursement for Medicare, Medicaid, VA-DOD, and private payers; and data-driven financial services due diligence to quantify risks, opportunities, and trends.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ADVI Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Organix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Organix
2.2 - Growth funds investing in similar companies to Organix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Organix
4.2 - Public trading comparable groups for Organix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →